Report overview
This report contains market size and forecasts of Veterinary Atopic Dermatitis in Global, including the following market information:
Global Veterinary Atopic Dermatitis Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Veterinary Atopic Dermatitis market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Oral Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Veterinary Atopic Dermatitis include GlenHaven, DermaPet, DVM Pharmaceuticals, Virbac, Enzo Life Sciences, Inc., Pfizer Animal Health, Novartis Animal Health, Inc., Eli Lilly and Company and Perrigo, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Veterinary Atopic Dermatitis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Veterinary Atopic Dermatitis Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Veterinary Atopic Dermatitis Market Segment Percentages, by Type, 2022 (%)
Oral
External Use
Injection
Global Veterinary Atopic Dermatitis Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Veterinary Atopic Dermatitis Market Segment Percentages, by Application, 2022 (%)
Veterinary Hospital
Veterinary Clinic
Global Veterinary Atopic Dermatitis Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Veterinary Atopic Dermatitis Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Veterinary Atopic Dermatitis revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Veterinary Atopic Dermatitis revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlenHaven
DermaPet
DVM Pharmaceuticals
Virbac
Enzo Life Sciences, Inc.
Pfizer Animal Health
Novartis Animal Health, Inc.
Eli Lilly and Company
Perrigo
Merck & Company
Zoetis Inc.
Toray Industries, Inc
Bayer Animal Health
Putney, Inc.
Dechra
Elanco
Kindred Biosciences
Nippon Zenyaku Kogyo Co., Ltd.
